Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 14
Item hits:
Issue DateTitleAuthor(s)
1-Mar-2019Efficacy and safety of prothrombin complex concentrate in patients treated with rivaroxaban or apixaban compared to warfarin presenting with major bleedingArachchillage, DRJ; Alavian, S; Griffin, J; Gurung, K; Szydlo, R, et al
May-2020Frequency of thrombocytopenia and heparin induced thrombocytopenia in patients receiving extracorporeal membrane oxygenation compared to cardiopulmonary bypass and the limited sensitivity of pre-test probability scoreJayakody Arachchillage, DR; Laffan, M; Khanna, S; Vandenbriele, C; Kamani, F, et al
1-Jan-2019Recommendations for the clinical interpretation of genetic variants and presentation of results to patients with inherited bleeding disorders. A UK Haemophilia Centre Doctors' Organisation Good Practice PaperGomez, K; Laffan, M; Keeney, S; Sutherland, M; Curry, N, et al
1-Aug-2019The top 10 research priorities in bleeding disorders: a James Lind Alliance Priority Setting PartnershipShapiro, S; Stephensen, D; Camp, C; Carroll, L; Collins, P, et al
Apr-2020What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?Arachchillage, DRJ; Laffan, M
-Rapid Response to: Clinical features of covid-19Davies, A; Onida, S; Shalhoub, J; Baker, C; Lawton, R, et al
12-Jul-2020Platelet function in patients with chronic myeloid leukemia treated with asciminibNesr, G; Laffan, M; Claudiani, S; Innes, A; Apperley, J, et al
1-Sep-2019Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patientsArachchillage, DRJ; Vipond, L; Laffan, M
1-Sep-2019Pathogenesis and management of thrombotic disease in myeloproliferative neoplasmsArachchillage, DR; Laffan, M
1-Jul-2020Effect of direct-acting oral anticoagulants (DOACs) on bleeding and blood product usage in cardiac surgery compared to warfarin and controlsLittle, C; Szydlo, R; Aw, TC; Laffan, M; Arachchillage, DRJ